Abstract:
We studied whether the high incidence of secondary amyloidosis (SA) is a consistent finding in patients with inflammatory joint disease. A total of 4508 biopsies of patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis were studied at the Rheumatism Foundation Hospital during 1987–1997. The results show that the annual number of findings of SA was reduced from 68 to less than 10. We suggest that a change in medication towards more frequent use of cytostatic agents is the reason for the reduction in incidence of SA.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 10 April 1998 / Accepted: 23 September 1998
Rights and permissions
About this article
Cite this article
Laiho, K., Tiitinen, S., Kaarela, K. et al. Secondary Amyloidosis has Decreased in Patients with Inflammatory Joint Disease in Finland. Clin Rheumatol 18, 122–123 (1999). https://doi.org/10.1007/s100670050068
Issue Date:
DOI: https://doi.org/10.1007/s100670050068